Epidemiological and clinical studies have shown that coffee consumption may reduce the levels of pro-inflammatory biomarkers such as interleukin(IL)-1b, IL-4, IL-6, IL-10, and C-reactive proteins, which can contribute to a reduced risk of type 2 diabetes [55,56,57]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.